Key result
This communication summarizes the methodological details, sampling requirements, and prognostic implications of 48-h ambulatory blood pressure monitoring in the MAPEC and Hygia Chronotherapy Trials.
Why the study?
The paper aims to summarize the methods for conducting, analyzing, and interpreting ABPM patient data in MAPEC and the Hygia Chronotherapy Trial, addressing limitations of 24 h BP mean recommendations.
Provides methodological justification for 48-h ABPM over 24-h ABPM in hypertension chronotherapy trials.
Answers are grounded in this paper and cite their sources.
48-h ABPM details inform chronotherapy research; leaves open superiority for routine hypertension management.
The specific purpose of this communication is to summarize the relevant details of the methods utilized to conduct, analyze, and interpret the ambulatory blood pressure (BP) monitoring (ABPM)-obtained patient data in both MAPEC and Hygia Chronotherapy Trial, including details of the sampling requirements in terms of duration and frequency, proper calculation of ABPM-derived mean values, prognostic and therapeutic implications of BP dipping, and limitations of the 24 h BP mean as diagnostic/prognostic parameter still mistakenly recommended by some hypertension guidelines.
No takes yet. Share an insight, caveat, or question.
Fernández et al. (2020) conducted a review in hypertension. 48-h ambulatory blood pressure monitoring (ABPM) vs. 24 h BP mean was evaluated. This communication summarizes the methodological details, sampling requirements, and prognostic implications of 48-h ambulatory blood pressure monitoring in the MAPEC and Hygia Chronotherapy Trials.
Synapse has enriched 10 related papers. Consider them for comparative context: